5th Aug 2009 10:42
PLETHORA SOLUTIONS HOLDINGS PLC
Holding in Company
Plethora Solutions Holdings PLC ("Plethora" or the "Company", AIM : PLE), the specialist developer of products for the treatment and management of urological disorders, received notification on 5 August 2009 in accordance with FSA Disclosure and Transparency Rules Transitional Provisions 7, that Gartmore Investment Limited no longer has a notifiable interest Company's issued share capital.
Enquiries:
|
Plethora Solutions Steven Powell |
Tel : +44(0) 20 3077 5400 |
|
FinnCap Geoff Nash |
Tel: +44(0) 20 7600 1658 |
|
Hansard Group Adam Reynolds/John Bick |
Tel: +44(0) 20 7245 1100 |
About Plethora:
Plethora is focused on the development and marketing of products for the treatment of urological disorders. The Company has products in clinical development for the treatment of overactive bladder (PSD506), stress urinary incontinence (PSD503), interstitial cystitis (PSD597), gynaecological pain (PSD508), erectile dysfunction (PSD510) and premature ejaculation (PSD502). The Company is headquartered in the UK and is listed on the London Stock Exchange (AIM:PLE)
Further information is available at www.plethorasolutions.co.uk
Related Shares:
Plethora Solutions Holdings Plc